Cargando…

Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins

Site-specific glycosylation analysis is key to investigate structure-function relationships of glycoproteins, e.g. in the context of antigenicity and disease progression. The analysis, though, is quite challenging and time consuming, in particular for O-glycosylated proteins. In consequence, despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Marcus, Marx, Kristina, Reichl, Udo, Wuhrer, Manfred, Rapp, Erdmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739677/
https://www.ncbi.nlm.nih.gov/pubmed/26598643
http://dx.doi.org/10.1074/mcp.M115.053546
_version_ 1782413784168529920
author Hoffmann, Marcus
Marx, Kristina
Reichl, Udo
Wuhrer, Manfred
Rapp, Erdmann
author_facet Hoffmann, Marcus
Marx, Kristina
Reichl, Udo
Wuhrer, Manfred
Rapp, Erdmann
author_sort Hoffmann, Marcus
collection PubMed
description Site-specific glycosylation analysis is key to investigate structure-function relationships of glycoproteins, e.g. in the context of antigenicity and disease progression. The analysis, though, is quite challenging and time consuming, in particular for O-glycosylated proteins. In consequence, despite their clinical and biopharmaceutical importance, many human blood plasma glycoproteins have not been characterized comprehensively with respect to their O-glycosylation. Here, we report on the site-specific O-glycosylation analysis of human blood plasma glycoproteins. To this end pooled human blood plasma of healthy donors was proteolytically digested using a broad-specific enzyme (Proteinase K), followed by a precipitation step, as well as a glycopeptide enrichment and fractionation step via hydrophilic interaction liquid chromatography, the latter being optimized for intact O-glycopeptides carrying short mucin-type core-1 and -2 O-glycans, which represent the vast majority of O-glycans on human blood plasma proteins. Enriched O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromatography coupled online to an ion trap mass spectrometer operated in positive-ion mode. Peptide identity and glycan composition were derived from low-energy collision-induced dissociation fragment spectra acquired in multistage mode. To pinpoint the O-glycosylation sites glycopeptides were fragmented using electron transfer dissociation. Spectra were annotated by database searches as well as manually. Overall, 31 O-glycosylation sites and regions belonging to 22 proteins were identified, the majority being acute-phase proteins. Strikingly, also 11 novel O-glycosylation sites and regions were identified. In total 23 O-glycosylation sites could be pinpointed. Interestingly, the use of Proteinase K proved to be particularly beneficial in this context. The identified O-glycan compositions most probably correspond to mono- and disialylated core-1 mucin-type O-glycans (T-antigen). The developed workflow allows the identification and characterization of the major population of the human blood plasma O-glycoproteome and our results provide new insights, which can help to unravel structure-function relationships. The data were deposited to ProteomeXchange PXD003270.
format Online
Article
Text
id pubmed-4739677
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-47396772016-02-22 Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins Hoffmann, Marcus Marx, Kristina Reichl, Udo Wuhrer, Manfred Rapp, Erdmann Mol Cell Proteomics Regular Articles Site-specific glycosylation analysis is key to investigate structure-function relationships of glycoproteins, e.g. in the context of antigenicity and disease progression. The analysis, though, is quite challenging and time consuming, in particular for O-glycosylated proteins. In consequence, despite their clinical and biopharmaceutical importance, many human blood plasma glycoproteins have not been characterized comprehensively with respect to their O-glycosylation. Here, we report on the site-specific O-glycosylation analysis of human blood plasma glycoproteins. To this end pooled human blood plasma of healthy donors was proteolytically digested using a broad-specific enzyme (Proteinase K), followed by a precipitation step, as well as a glycopeptide enrichment and fractionation step via hydrophilic interaction liquid chromatography, the latter being optimized for intact O-glycopeptides carrying short mucin-type core-1 and -2 O-glycans, which represent the vast majority of O-glycans on human blood plasma proteins. Enriched O-glycopeptide fractions were subjected to mass spectrometric analysis using reversed-phase liquid chromatography coupled online to an ion trap mass spectrometer operated in positive-ion mode. Peptide identity and glycan composition were derived from low-energy collision-induced dissociation fragment spectra acquired in multistage mode. To pinpoint the O-glycosylation sites glycopeptides were fragmented using electron transfer dissociation. Spectra were annotated by database searches as well as manually. Overall, 31 O-glycosylation sites and regions belonging to 22 proteins were identified, the majority being acute-phase proteins. Strikingly, also 11 novel O-glycosylation sites and regions were identified. In total 23 O-glycosylation sites could be pinpointed. Interestingly, the use of Proteinase K proved to be particularly beneficial in this context. The identified O-glycan compositions most probably correspond to mono- and disialylated core-1 mucin-type O-glycans (T-antigen). The developed workflow allows the identification and characterization of the major population of the human blood plasma O-glycoproteome and our results provide new insights, which can help to unravel structure-function relationships. The data were deposited to ProteomeXchange PXD003270. The American Society for Biochemistry and Molecular Biology 2016-02 2015-11-23 /pmc/articles/PMC4739677/ /pubmed/26598643 http://dx.doi.org/10.1074/mcp.M115.053546 Text en © 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Author's Choice—Final version free via Creative Commons CC-BY license (http://creativecommons.org/licenses/by/4.0) .
spellingShingle Regular Articles
Hoffmann, Marcus
Marx, Kristina
Reichl, Udo
Wuhrer, Manfred
Rapp, Erdmann
Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title_full Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title_fullStr Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title_full_unstemmed Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title_short Site-specific O-Glycosylation Analysis of Human Blood Plasma Proteins
title_sort site-specific o-glycosylation analysis of human blood plasma proteins
topic Regular Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739677/
https://www.ncbi.nlm.nih.gov/pubmed/26598643
http://dx.doi.org/10.1074/mcp.M115.053546
work_keys_str_mv AT hoffmannmarcus sitespecificoglycosylationanalysisofhumanbloodplasmaproteins
AT marxkristina sitespecificoglycosylationanalysisofhumanbloodplasmaproteins
AT reichludo sitespecificoglycosylationanalysisofhumanbloodplasmaproteins
AT wuhrermanfred sitespecificoglycosylationanalysisofhumanbloodplasmaproteins
AT rapperdmann sitespecificoglycosylationanalysisofhumanbloodplasmaproteins